TrialScientific reports2026

Levofloxacin versus moxifloxacin in nitazoxanide-based quadruple therapy as a first-line treatment for Helicobacter pylori infection: NILE, a randomized, comparative, multicenter study.

Gasser El-Azab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.